Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 947-954

  Ewing, James F ^a   Young, Delano V ^a   Janero, David R ^a   Garvey, David S ^a   Grinnell, Todd A ^a  

^a NitroMed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; DITHIOTHREITOL; HOMOCYSTEINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROSO DERIVATIVE; PALMITIC ACID;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; REDUCTION; VASCULAR SMOOTH MUSCLE;

CELL DIVISION; CELLS, CULTURED; CHROMATOGRAPHY, GEL; FATTY ACIDS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROSO COMPOUNDS; SERUM ALBUMIN, BOVINE;

EID: 0030732453     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ARONSTAM, R. S., MARTIN, D. C., DENNISON, R. L. AND COOLEY, H. G.: S-nitrosylation of m2 muscarinic receptor thiols disrupts receptor-G-protein coupling. Ann. N.Y. Acad. Sci. 757: 215-217, 1995.
2. BENESCH, R. AND BENESCH, R. E.: Thiolation of proteins. Proc. Natl. Acad. Sci. U.S.A. 44: 848-853, 1958.
3. BURCZYNSKI, F. J., POND, S. M., DAVIES, C. K., JOHNSON, L. P. AND WEISIGER, R. A.: Calibration of albumin-fatty acid binding constants measured by heptane-water partition. Am. J. Physiol. 265: G555-G563, 1993.
4. BURCZYNSKI, F. J., WANG, G. AND HNATOWICH, M.: Effect of nitric oxide on albumin-palmitate binding. Biochem. Pharmacol. 49: 91-96, 1995.
5. CARTER, D. C. AND HO, J. X.: Structure of albumin. Adv. Protein Chem. 45: 153-203, 1994.
6. DAVIES, K. J. A., LIN, S. W. AND PACIFICI, R. E.: Protein damage and degradation by oxygen radicals: IV. Degradation of denatured protein. J. Biol. Chem. 262: 9914-9920, 1992.
7. DIERKS, E. A. AND BURSTYN, J. N.: Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase. Biochem. Pharmacol. 51: 1593-1600, 1996.
8. DINERMAN, J. L., LOWENSTEIN, C. J. AND SNYDER, S. H.: Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Circ. Res. 73: 217-222, 1993.
9. EWING, J. F. AND JANERO, D. R.: Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal. Biochem. 232: 242-248, 1995.
10. EWING, J. F., JANERO, D. R., GRINNELL, T. A., SCHROEDER, J. D. AND GARVEY, D. S.: Reactivity of nitrogen monoxide species with NADH: implications for nitric oxide-dependent posttranslational protein modification. Arch. Biochem. Biophys. 343: 131-139, 1997.
11. FURCHGOTT, R. F. AND ZAWADSKI, J. F.: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376, 1980.
12. GROSS, S. S. AND WOLIN, M. S.: Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57: 737-769, 1995.
13. IGNARRO, L. J., LIPTON, H., EDWARDS, J., BARICOS, W. H., HYMAN, A. L., KADOWITZ, P. J. AND GRUETTER, C. A.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218: 739-749, 1981.
14. JAKUBOWSKI, H.: Metabolism of homocysteine thiolactone in human cell cultures. Possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 272: 1935-1942, 1997.
15. JANERO, D. R. AND HRENIUK, D.: Suppression of TCA cycle activity in the cardiac muscle cell by hydroperoxide-induced oxidant stress. Am. J. Physiol. 270: C1735-C1742, 1996.
16. KATCHALSKI, E., BENJAMIN, G. S. AND GROSS, V.: The availability of the disulfide bonds of human and bovine serum albumin and of bovine 235 -globulin to reduction by thioglycolic acid. J. Am. Chem. Soc. 79: 4096-4099, 1957.
17. KEANEY, J. F., SIMON, D. I., STAMLER, J. S., JARAKI, O., SCHARFSTEIN, J., VITA, J. A. AND LOSCALZO, J.: NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91: 1582-1589, 1993.
18. LAEMMLI, U. K.: Cleavage of structural proteins during the assembly of the bacteriophage T4. Nature 227: 680-685, 1970.
19. LANDER, H. M., OGISTE, J. S., PEARCE, S. F. A., LEVI, R. AND NOVOGRODSKY, A.: p21 ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270: 7017-7020, 1995.
20. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement using the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
21. MAHONEY, C. W., PAK, J. H. AND HUANG, K.-P.: Nitric oxide modification of rat brain neurogranin. Identification of the cysteine residue involved in intramolecular disulfide bridge formation using site-directed mutagenesis. J. Biol. Chem. 271: 28798-28804, 1996.
22. MARKS, D. S., VITA, J. A., FOLTS, J. D., KEANEY, J. F., JR., WELCH, G. N. AND LOSCALZO, J.: Inhibition of neointimal proliferation in rabbit after vascular injury by a single treatment with a protein adduct of nitric oxide. J. Clin. Invest. 96: 2630-2638, 1995.
23. MATHEWS, W. R. AND KERR, S. W. J.: Biological activity of S-nitrosothiols: the role of nitric oxide. J. Pharmacol. Exp. Ther. 267: 1529-1537, 1993.
24. MAYER, E. L., JACOBSEN, D. W. AND ROBINSON, K.: Homocysteine and coronary atherosclerosis. J. Am. Coll. Cardiol. 27: 517-527, 1996.
25. MINAMIYAMA, Y., TAKEMURA, S. AND INOUE, M.: Albumin is an important vascular tonus regulator as a reservoir of nitric oxide. Biochem. Biophys. Res. Commun. 225: 112-115, 1996.
26. MINTZ, G. S., POPMA, J. J., PICHARD, A. D., KENT, K. M., SATTER, L. F., WONG, C., HONG, M. K., KOVACH, J. A. AND LEON, M. B.: Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94: 35-43, 1996.
27. MOORADIAN, D. L., HUSTELL, T. C. AND KEEFER, L. K.: Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol. 25: 674-678, 1995.
28. MYERS, P. R., MINOR, R. L., JR., GUERRA, R., JR., BATES, J. N. AND HARRISON, D. G.: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345: 161-163, 1990.
29. PRYOR, W. A. AND SQUADRITO, G. L.: The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 288: L669-L722, 1995.
30. SARKAR, R., MEINBERG, E. G., STANLEY, J. C., GORDON, D. AND WEBB, R. C.: Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78: 225-230, 1996.
31. SAVILLE, B.: A scheme for colorimetric determination of microgram amounts of thiols. Analyst 83: 670-672, 1958.
32. SCORZA, G., PIETRAFORTE, D. AND MINETTI, M.: Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitrosoglutathione in human plasma. Free Radical Biol. Med. 22: 633-642, 1997.
33. SEDLAK, J. AND LINDSAY, R. H.: Estimation of total protein-bound and nonprotein-bound sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 25: 192-205, 1968.
34. SHAW, L. A., RUDIN, M. AND COOK, N. S.: Pharmacological inhibition of restenosis: learning from experience. Trends Pharmacol. Sci. 16: 401-405, 1995.
35. SIMON, D. I., MULLINS, M. E., JIA, L., GASTON, B., SINGEL, D. J. AND STAMLER, J. S: Polynitrosylated proteins: characterization, bioactivity and functional consequences. Proc. Nat. Acad. Sci. U.S.A. 93: 4736-4741, 1996.
36. SINGH, R. J., HOGG, N., JOSEPH, J. AND KALYANARAMAN, B.: Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271: 18596-18603, 1996.
37. STAMLER, J. S., JARAKI, O., OSBORNE, J., SIMON, D. I., KEANEY, J., VITA, J., SINGEL, D., VALERI, C. R. AND LOSCALZO, J.: Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. U.S.A. 89: 7674-7677, 1992.